Ignite Creation Date:
2025-12-24 @ 11:36 PM
Ignite Modification Date:
2026-02-23 @ 4:54 AM
Study NCT ID:
NCT02711956
Status:
COMPLETED
Last Update Posted:
2021-11-30
First Post:
2016-03-14
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of ZEN003694 in Combination With Enzalutamide in Patients With Metastatic Castration-Resistant Prostate Cancer
Sponsor:
Zenith Epigenetics
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Metastatic Castration-Resistant Prostate Cancer | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Metastatic Castration-Resistant Prostate Cancer (mCRPC) | View |
| None | Phase 1b/2a | View |
| None | Prostate Cancer | View |
| None | Pharmacokinetics (PK) | View |
| None | ZEN003694 | View |
| None | ZEN-3694 | View |
| None | Metastatic Castrate-Resistant Prostate Cancer | View |
| None | BET inhibitor (BETi) | View |
| None | Bromodomain | View |
| None | Pharmacodynamics (PD) | View |
| None | Enzalutamide | View |
| None | XTANDI | View |
| None | MDV3100 | View |
| None | Epigenetics | View |